Iris melanoma
MONDO:0004064A uveal melanoma that arises from the iris. It is the most common primary malignant neoplasm of the iris. The majority arise in preexisting nevi.
Also known as: iris malignant melanoma, iris melanoma, iris melanoma (disease), malignant melanoma of iris, malignant melanoma of the iris, melanoma (disease) of iris, melanoma of iris, melanoma of the iris
2844 clinical trials for this condition and its sub-types, 4 tagged with Iris melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Iris melanoma
-
Intermediate cell type iris melanoma 0 trials
1 sub-type
-
Iris spindle cell melanoma 0 trials
1 sub-type
- Ciliary body spindle cell melanoma 0 trials
-
Malignant ciliary body melanoma 0 trials
4 sub-types
- Ciliary body epithelioid cell melanoma 0 trials
- Ciliary body mixed cell melanoma 0 trials
- Ciliary body spindle cell melanoma 0 trials
- Intermediate cell type ciliary body melanoma 0 trials
-
Can a vaccine keep melanoma from coming back? large trial tests immune boosters
Disease control CompletedThis phase 3 trial tested whether a yeast-derived immune stimulant (GM-CSF) and a peptide vaccine, alone or together, could prevent melanoma from returning after surgery. 815 patients with no visible cancer after complete surgical removal of advanced melanoma were randomly assign…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Supercharged immune cells take on tough melanoma
Disease control CompletedThis early-phase trial tested a new personalized therapy called TBio-4101 for people with advanced melanoma that had stopped responding to standard treatments. The therapy uses a patient's own tumor-fighting immune cells, which are collected, multiplied in the lab, and then infus…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC